INDUSTRY NEWS

Fitbit in healthcare partnership to take on Apple Watch

Published Date | 2019 October 18

Global: Fitbit Inc FIT.N is building up a technique to identify irregular heartbeat in time through an association with Bristol-Myers Squibb-Pfizer Alliance, as the wearable device producer hopes to coordinate a component accessible on opponent Apple Inc's AAPL.O Watch. Fitbit has been pushing further into the healthcare segment and in August tied up with the Singapore government to give wellness trackers and administrations in a wellbeing program that the organization said could reach up to one million clients. The device will carry atrial fibrillation detection software after discussion and approval from the U.S FDA.

According to BlueWeave Consulting, rising rate of geriatric population, diabetes, obesity, cardiovascular disease and other chronic disorder enhancement which rise the demand of a better healthcare system. Atrial fibrillation is a disorder condition in which heart rhythm rate is high couple with major risk of stroke. About 2.7 million to 6 million individuals experience the suffering in the United States, as indicated by the Centers for Disease Control and Prevention. Atrial fibrillation indicates the rapid or irregular rate of heart rhythm that raises the risk of heart, stroke, and other health complications, such as angina, chest pain responsible for congestive heart failure. The common identification symptoms of atrial fibrillation are confusion, dizziness, fatigue, and fainting.

According to upcoming report BlueWeave Consulting report titled “Global Atrial Fibrillation Market by Type (Surgical [Maze Surgery and Catheter Ablation] and Non-Surgical [Electric Cardioversion, Pharmacological Drugs, Diagnostic Devices, Mapping and Recording Systems, Cardiac Monitors, Access Devices, and Left Atrial Appendage and Closure Devices]) By Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America); Size and Forecast, 2018-2025

The upcoming report statistic anticipated growth at a CAGR of approx. 13.9% in atrial fibrillation market with the rising rate of chronic cardio disorders such as obesity, hypertension and diabetic population worldwide. The rising preference towards cardiovascular screening devices or maintaining devices for monitoring rhythm rate of heart to avoid cardio surgeries for some instance. Rising disposable income, preference shift towards junk food, change in lifestyle are the factor expected to drive the demand of the global atrial fibrillation market in the forecast period with the significant growth rate. Rising technological advancement in terms of patient comfort, time reduction and feasible handling of detection or maintaining devices play a vital role for earlier detection to avoid stroke.